tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Keyur Parekh, 6 are a BUY (75%), 2 are a HOLD (25%).
Analyst Keyur Parekh, carries an average stock price target met ratio of 50% that have a potential upside of 30.6% achieved within 627 days.
Keyur Parekh’s has documented 15 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 23-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/26/2022. The price target of $60.58 was fulfilled within 316 days with a profit of $17 (39.01%) receiving and performance score of 1.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$87
$2.47 (2.92%)
$78
10 months 29 days ago
(17-Nov-2024)
8/9 (88.89%)
$24.91 (40.12%)
639
Buy
$88
$3.47 (4.11%)
$82
11 months 4 days ago
(12-Nov-2024)
4/5 (80%)
$24.05 (37.61%)
315
Buy
$95
$10.47 (12.39%)
$66
1 years 2 months 5 days ago
(12-Aug-2024)
6/7 (85.71%)
$14.17 (17.53%)
501
Buy
$85
$0.47 (0.56%)
$80
1 years 4 months 17 days ago
(30-May-2024)
4/4 (100%)
$10.26 (13.73%)
414
Buy
$84
$-0.53 (-0.63%)
$85
1 years 5 months 25 days ago
(22-Apr-2024)
2/12 (16.67%)
$15.73 (23.04%)
170
What Year was the first public recommendation made by Keyur Parekh?
